Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaBone MarrowTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsMelphalanBone Marrow TransplantationTransplantation ConditioningCombined Modality TherapyBone Marrow CellsTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalCyclophosphamideEtoposideHodgkin DiseaseLymphoma, Non-HodgkinBone Marrow PurgingRecurrenceCytarabineGraft vs Host DiseaseMyeloablative AgonistsHematopoietic Stem CellsSpleenCarmustineHematopoietic Stem Cell MobilizationSurvival RateThiotepaWhole-Body IrradiationVincristineHematologic NeoplasmsSurvival AnalysisLymphoma, Mantle-CellRetrospective StudiesBusulfanAmyloidosisBone and BonesDoxorubicinGraft SurvivalPrognosisAntigens, CD34DexamethasoneBoronic AcidsPyrazinesFollow-Up StudiesTime FactorsAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularLymphoma, T-Cell, PeripheralAntineoplastic Agents, AlkylatingGranulocyte Colony-Stimulating FactorAutograftsAntineoplastic AgentsMesenchymal Stem Cell TransplantationLiver TransplantationThalidomideIfosfamideLymphomaTransplantation ChimeraInduction ChemotherapyLeukapheresisPrednisoneLeukemia, Myeloid, AcutePodophyllotoxinNeoplasm, ResidualTissue DonorsLymphoma, Large B-Cell, DiffuseHematopoiesisCell DifferentiationMyelodysplastic SyndromesMaintenance ChemotherapyCord Blood Stem Cell TransplantationCell TransplantationLymphoma, B-CellAntibodies, MonoclonalKidney TransplantationBone Marrow DiseasesEmbryonic Stem CellsMitoxantroneLeukemiaHistocompatibility TestingIdarubicinEnteropathy-Associated T-Cell LymphomaLeukemia, MyeloidProspective StudiesLeukemia, Plasma CellImmunosuppressive AgentsNeoplasms, Second PrimaryCells, CulturedT-LymphocytesCisplatinAdult Stem CellsInfusions, SpinalBlood Component RemovalCarboplatin